MIAMI (CBSMiami) – A leading health insurer will no longer cover the Epi-Pen.
Cigna has announced that it will only cover a lesser priced generic version that Epi-Pen’s manufacturer, Mylan, launched last month.
The Epi-Penis used to help stop life threatening allergic reactions.
Mylan has been under fire for raising the price of Epi-Pens more than 400-percent since 2009. A two-pack currently costs more than $600. The generic version costs half of that.